| Literature DB >> 35784441 |
Hui Liu1, Jing Li2, Jingyu Guo3, Yuan Shi3, Li Wang4.
Abstract
Background: Neonatal acute respiratory distress syndrome (ARDS) is a critical clinical disease with high disability and mortality rates. Early identification and treatment of neonatal ARDS is critical. This study aimed to build a perinatal prediction nomogram for early prediction of neonatal ARDS.Entities:
Keywords: Full-term infants; Late-preterm infants; Neonatal acute respiratory distress syndrome; Prediction nomogram
Year: 2022 PMID: 35784441 PMCID: PMC9241127 DOI: 10.1016/j.eclinm.2022.101523
Source DB: PubMed Journal: EClinicalMedicine ISSN: 2589-5370
Figure 1Flow chart for patient selection. GA = gestational age; RDS = respiratory distress syndrome; TTN = transient tachypnoea of the neonate; ARDS = acute respiratory distress syndrome. *Maternal age (n = 3), mother's education level (n = 6), chorioamnionitis (n = 5), placenta abnormality (n = 3), mother's education level and chorioamnionitis (n = 2), maternal age and pre-existing disease before pregnancy (n = 2).
Baseline characteristics of all patients in the training cohort and validation cohort.
| Variables | Training cohort( | Validation cohort( | ||
|---|---|---|---|---|
| GA (weeks) | 36·9 (35·3, 39·4) | 37·9 (36·1, 39·6) | 0·232 | |
| Birth weight (kilograms) | 2·9 (2·5, 3·4) | 3·2 (2·6, 3·4) | 0·125 | |
| Gender | Male | 137 (56·4) | 53 (66·3) | 0·120 |
| Female | 106 (43·6) | 27 (33·8) | ||
| Apgar 5-min | 10 (9, 10) | 10 (9, 10) | 0·346 | |
| Amniotic fluid contamination | + | 69 (28·4) | 19 (23·8) | 0·418 |
| − | 174 (71·6) | 61 (76·3) | ||
| Mode of delivery | Caesarean delivery | 171 (70·4) | 57 (71·3) | 0·881 |
| vaginal delivery | 72 (29·6) | 23 (28·8) | ||
| Maternal age (years) | 20-35 | 194 (79·8) | 65 (81·3) | 0·783 |
| <20 or ≥35 | 49 (20·2) | 15 (18·8) | ||
| Mother's education level (years) | ≤9 | 55 (22·6) | 21 (26·3) | 0·531 |
| 10-12 | 49 (20·2) | 19 (23·8) | ||
| ≥13 | 139 (57·2) | 40 (50·0) | ||
| Smoking/Drug | + | 3 (1·2) | 2 (2·5) | 0·785 |
| − | 240 (98·8) | 78 (97·5) | ||
| Regular antenatal care | + | 240 (98·8) | 74 (92·5) | 0·010 |
| − | 3 (1·2) | 6 (7·5) | ||
| Hospital level | level III | 147 (60·5) | 50 (62·5) | 0·750 |
| level II or below | 96 (39·5) | 30 (37·5) | ||
| Pre-existing disease before pregnancy | + | 32 (13·2) | 11 (13·8) | 0·894 |
| − | 211 (86·8) | 69 (86·3) | ||
| PROM | + | 62 (25·5) | 16 (20·0) | 0·318 |
| − | 181 (74·5) | 64 (80·0) | ||
| CA | + | 17 (7·0) | 1 (1·3) | 0·096 |
| − | 226 (93·0) | 79 (98·8) | ||
| Infectious disease within 7 days before delivery | + | 21 (8·6) | 12 (15·0) | 0·103 |
| − | 222 (91·4) | 68 (85·0) | ||
| Fetal distress | + | 41 (16·9) | 13 (16·3) | 0·897 |
| − | 202 (83·1) | 67 (83·8) | ||
| Umbilical cord abnormality | + | 67 (27·6) | 15 (18·8) | 0·116 |
| − | 176 (72·4) | 65 (81·3) | ||
| Placenta abnormality | + | 35 (14·4) | 15 (18·8) | 0·351 |
| − | 208 (85·6) | 65 (81·3) | ||
| GDM | + | 72 (29·6) | 12 (15·0) | 0·010 |
| − | 171 (70·4) | 68 (85·0) | ||
| ICP | + | 21 (8·6) | 5 (6·3) | 0·495 |
| − | 222 (91·4) | 75 (93·8) | ||
| HDP | + | 27 (11·1) | 5 (6·3) | 0·207 |
| − | 216 (88·9) | 75 (93·8) | ||
| Other complications | + | 61 (25·1) | 11 (13·8) | 0·034 |
| − | 182 (74·9) | 69 (86·3) |
+= yes; −= no; GA = gestational age; Hospital level = The level of hospital where mothers went for antenatal care; PROM = premature rupture of membrane; CA = chorioamnionitis; GDM = gestational diabetes mellitus; ICP = intrahepatic cholestasis of pregnancy; HDP = hypertensive disorders of pregnancy.
General characteristics of the patients and multivariate logistic regression analyses for screening predictors.
| Variables | ARDS( | Non-ARDS( | OR | OR 95% CI | |||
|---|---|---|---|---|---|---|---|
| GA (weeks) | 37·9 (35·4, 39·4) | 36·4 (35·1, 39·0) | 0·069 | 2·131 | 0·942 | 4·819 | |
| Birth weight(kilograms) | 3·1 (2·6, 3·5) | 2·8 (2·3, 3·4) | 0·190 | 1·792 | 0·748 | 4·291 | |
| Gender | Male | 64 (61·5) | 73 (52·5) | 0·287 | 0·700 | 0·363 | 1·350 |
| Female | 40 (38·5) | 66 (47·5) | |||||
| Apgar 5-min | 10 (8, 10) | 10 (9, 10) | 0·007 | 0·717 | 0·563 | 0·913 | |
| Amniotic fluid contamination | + | 37 (35·6) | 32 (23·0) | 0·944 | 1·030 | 0·449 | 2·365 |
| − | 67 (64·4) | 107 (77·0) | |||||
| Mode of delivery | Caesarean delivery | 72 (69·2) | 99 (71·2) | 0·586 | 1·235 | 0·577 | 2·646 |
| vaginal delivery | 32 (30·8) | 40 (28·8) | |||||
| Maternal age(years) | 20-35 | 82 (78·8) | 112 (80·6) | 0·723 | 0·855 | 0·360 | 2·031 |
| <20 or ≥35 | 22 (21·1) | 27 (19·4) | |||||
| Mother's education level(years) | ≤9 | 34 (32·7) | 21 (15·1) | 0·000 | 0·478 | 0·324 | 0·704 |
| 10-12 | 28 (26·9) | 21 (15·1) | |||||
| ≥13 | 42 (40·4) | 97 (69·8) | |||||
| Smoking/Drug | + | 2 (1·9) | 1 (0·7) | 0·676 | 0·507 | 0·021 | 12·201 |
| − | 102 (98 ·1) | 138 (99·3) | |||||
| Regular antenatal care | + | 101 (98·1) | 138 (99·3) | 0·660 | 1·758 | 0·142 | 21·745 |
| − | 2 (1·9) | 1 (0·7) | |||||
| Hospital level | level III | 49 (47·1) | 98 (70·5) | 0·009 | 2·479 | 1·260 | 4·877 |
| level II or below | 55 (52·9) | 44 (31·7) | |||||
| Pre-existing disease before pregnancy | + | 14 (13·5) | 18 (12·9) | 0·173 | 0·520 | 0·203 | 1·331 |
| − | 90 (86·5) | 121 (87·1) | |||||
| PROM | + | 32 (30·8) | 30 (21·6) | 0·003 | 0·296 | 0·133 | 0·655 |
| − | 72 (69·2) | 109 (78·4) | |||||
| CA | + | 10 (9·6) | 7 (5·0) | 0·526 | 0·663 | 0·187 | 2·359 |
| − | 94 (90·4) | 132 (95·0) | |||||
| Infectious disease within 7 days before delivery | + | 15 (14·4) | 6 (4·3) | 0·034 | 0·275 | 0·083 | 0·909 |
| − | 89 (85·6) | 133 (95·7) | |||||
| Fetal distress | + | 26 (25·0) | 15 (10·8) | 0·055 | 0·399 | 0·156 | 1·018 |
| − | 78 (75·0) | 124 (89·2) | |||||
| Umbilical cord abnormality | + | 31 (29·8) | 36 (25·9) | 0·670 | 0·862 | 0·436 | 1·706 |
| − | 73 (70·2) | 103 (74·1) | |||||
| Placenta abnormality | + | 20 (19·2) | 15 (10·8) | 0·103 | 0·465 | 0·185 | 1·168 |
| − | 84 (80·8) | 124 (89·2) | |||||
| GDM | + | 30 (28·9) | 42 (30·2) | 0·524 | 0·795 | 0·393 | 1·609 |
| − | 74 (71·1) | 97 (69·8) | |||||
| ICP | + | 9 (8·7) | 12 (8·6) | 0·430 | 0·625 | 0·194 | 2·008 |
| − | 95 (91·3) | 127 (91·4) | |||||
| HDP | + | 9 (8·7) | 18 (12·9) | 0·966 | 1·024 | 0·344 | 3·047 |
| − | 95 (91·3) | 121(87·1) | |||||
| Other complications | + | 24 (23·1) | 37 (26·6) | 0·480 | 0·761 | 0·358 | 1·621 |
| − | 80 (76·9) | 102 (73·4) | |||||
+= yes; −= no; GA = gestational age; Hospital level = The level of hospital where the mother went for antenatal care; PROM = premature rupture of membrane; CA = chorioamnionitis; GDM = gestational diabetes mellitus; ICP = intrahepatic cholestasis of pregnancy; HDP = hypertensive disorders of pregnancy; OR = odds ratio; CI = confidence interval; L = lower limit; U = upper limit.
Figure 2Nomogram for the perinatal prediction of neonatal ARDS. ARDS = acute respiratory distress syndrome.
Figure 3ROC curves. (A) Training cohort. (B) Validation cohort. ROC=receiver operating characteristic; AUC=area under the ROC curve.
Figure 4Calibration curve for predicting probability of neonatal ARDS. (A) Training cohort. (B) Validation cohort. ARDS = acute respiratory distress syndrome.
Figure 5Decision curve analysis in prediction of neonatal ARDS. (A) Training cohort. (B) Validation cohort. ARDS = acute respiratory distress syndrome.